cov pid 1 [ . . . . ] 45 1 NFX1_HUMAN/1-3 100.0% 100.0% CGSLDFIHTCEKL----CHE-GD-----CGPVSRT---SVISCRC 2 AAD38654/1-20 62.5% 31.2% CG----KHKCDQP----CHR-GN-----CPP-----------CYR 3 NFX1_HUMAN_1/1 62.5% 31.2% CG----LHRCEEP----CHR-GN-----CQT-----------CWQ 4 YNC3_YEAST/1-2 62.5% 34.4% CG----IHKCQRK----CHP-GK-----CPP-----------CLE 5 34|Q18034/1-20 62.5% 40.6% CG----IHTCENV----CHA-GQ-----CRP-----------CLQ 6 YNC3_YEAST_1/1 62.5% 30.3% CY-----HTCQKT----CHLPGN-----CQK----------VCKQ 7 NFX1_HUMAN_2/1 71.9% 31.2% CG----MHKCQRL----CHK-GE-----CLVD--------EPCKQ 8 NFX1_HUMAN_3/1 62.5% 28.1% CG----NHTCSQV----CHP-QP-----CQQ-----------CPR 9 AAD32867/1-20 62.5% 34.4% CG----RHQCERT----CHV-GP-----CDP-----------CQV 10 STC_DROME_1/1- 75.0% 37.5% CG----GHKCIKP----CHE-GP-----CQSAG-------EICRQ 11 YNC3_YEAST_2/1 62.5% 40.6% CS----IHTCKKK----CHP-GL-----CGP-----------CPE 12 YNC3_YEAST_3/1 65.6% 25.0% CG----KHSCPFT----CHD-KA-----CME----------PCLQ 13 YNC3_YEAST_4/1 59.4% 25.0% CM-----HGCSKI----CHL-GP-----HPE-----------CTR 14 AAD38654_2/1-2 65.6% 31.2% CG-----HKCAAA----CHE-GA-----CPET---------PCKE 15 NFX1_HUMAN_4/1 62.5% 34.4% CG----QHQCAEL----CHG-GQ-----CQP-----------CQI 16 AAD38654_3/1-2 62.5% 31.2% CG----HHKCKDS----CHA-GS-----CRP-----------CKL 17 NFX1_HUMAN_5/1 59.4% 31.2% CP-----HSCNLL----CHP-GP-----CPP-----------CPA 18 AAD38654_4/1-2 62.5% 28.1% CG----EHRCQAE----CHS-GK-----CAA-----------CSE 19 AAD32867_1/1-2 62.5% 31.2% CG----NHFCSEV----CHP-GP-----CGD-----------CDL 20 STC_DROME_5/1- 75.0% 31.2% CGKPAHPHQCGSK----CHL-GQ-----CPP-----------CPK 21 AAD32867_2/1-2 62.5% 37.5% CG----QHSCESL----CHS-GH-----CPP-----------CLE 22 34|Q18034_1/1- 62.5% 37.5% CG----QHNCERI----CHS-GD-----CGE-----------CTV 23 AAD38654_6/1-1 59.4% 31.2% CS-----HACTLL----CHP-GP-----CPP-----------CQA 24 NFX1_HUMAN_6/1 65.6% 24.2% CG-----HPCMAP----CHTSSP-----CPVT---------ACKA 25 AAD32867_3/1-3 87.5% 25.7% CG----MHACART----CHP-EP-----CDSFNESEAGMRVTCRQ 26 AAD32867_4/1-2 62.5% 34.4% CR----LHTCNEM----CHA-GD-----CPP-----------CLV 27 NFX1_HUMAN_7/1 59.4% 18.2% CG----RHKCNEI----CCVDKE-----HK------------CPL 28 STC_DROME_7/1- 59.4% 21.2% CG----KHKCNVE----CCIDID-----HD------------CPL 29 53|O74853/1-20 62.5% 37.5% CG----EHTCKKR----CHS-GL-----CGA-----------CFE 30 53|O74853_1/1- 59.4% 31.2% CG-----HRCKYK----CHL-GS-----CGT-----------CSE 31 53|O74853_2/1- 62.5% 28.1% CG----NHFCQHM----CHR-GP-----CPR-----------CLE 32 34|Q18034_2/1- 75.0% 34.4% CGTPGKNHHCREK----CHE-GP-----CPP-----------CNL 33 34|Q18034_3/1- 59.4% 28.1% CP-----HPCTEL----CHP-GP-----CIE-----------CKL 34 53|O74853_3/1- 59.4% 31.2% CE-----HPCPLL----CHP-GP-----CPP-----------CTA 35 34|Q18034_4/1- 62.5% 34.4% CG----IHHCTKK----CHD-KE-----CGE-----------CET 36 AAD32867_5/1-1 59.4% 28.1% CP-----HVCVLQ----CHP-GP-----CPP-----------CKA 37 53|O74853_4/1- 65.6% 36.4% CK----THFCEKL----CHPDGE-----CES----------SCKK 38 34|Q18034_5/1- 59.4% 18.2% CG----MHKCQEV----CCIQDE-----HF------------CLQ 39 34|Q18034_6/1- 65.6% 27.3% CE-----HPCALP----CHEDSP-----CEPS---------PCKA 40 AAD32867_6/1-2 65.6% 27.3% CR-----HTCAAL----CHPSAP-----CPDL---------RCEF 41 34|Q18034_7/1- 75.0% 25.0% CG----VHVCQRT----CHG-EE-----CEKEG-------EKCTK 42 53|O74853_5/1- 84.4% 27.0% CG----LHKCSKT----CHP-ISETRAHCPFATD----VLTKCPC 43 AAD32867_7/1-1 59.4% 31.2% CG-----HSDTHG----CHF-GD-----CPP-----------CST 44 53|O74853_7/1- 68.8% 24.2% CE-----HVCQSP----CHAGHP-----CDER--------IPCKA 45 34|Q18034_8/1- 59.4% 21.2% CD-----HSVSHK----CHGEQN-----CPP-----------CTQ 46 YNC3_YEAST_5/1 65.6% 24.2% CN-----HECPKP----CHGKTE-----CPDL---------PCAT 47 YNC3_YEAST_6/1 59.4% 22.9% CG-----HKPMPHT---CHSLDVS----CPP-----------CTE 48 STC_DROME_8/1- 59.4% 24.2% CD-----HPPQHN----CHS-GP----TCPP-----------CMI 49 AAD38654_8/1-2 65.6% 27.0% CS---RIHPCDHPPQHNCHS-GP----TCPP-----------CMI consensus/100% C......H.s.......Cp.........p.............C.. consensus/90% C......H.C.......CH..t......C.............C.. consensus/80% Cs.....H.Ctt.....CH..t......C.............C.. consensus/70% Cu.....HtCpph....CH..u......C.............C.t